CD8A and neoplasm: Analysis of immune subsets in blood following AZA treatment, however, appears to decrease the frequency of suppressive cell type scores (neutrophils and Treg), while increasing anti-tumor cell type scores like CD8 + T-cells, which is conducive for anti-leukemic immunity.